Alere INRatio®2 PT/INR Monitoring System
Alere INRatio® and INRatio®2 PT/INR Monitoring System Voluntary Withdrawal
Alere is initiating a voluntary withdrawal for the Alere INRatio® and INRatio®2 PT/INR Monitor System. If you or your patients use the Alere INRatio® or INRatio® 2 Monitor and INRatio® Test Strips, you may be affected.
Alere INRatio® PT/INR Test Strip
The keys to true portability are test strip packaging, ease of use, and robust quality controls. Confidence in the integrity of the test strip provides confidence in the integrity of the test result in all testing environments.
- The Seventh ACCP Conference on Anticoagulation Therapy: Evidence-Based Guidelines, Supplement to Chest, Volume 126, No. 3. September 2004: 2085-2095.
- HPIS comparative sales data, point of care PT/INR monitors sold 2005-2009
- Decousser et al., American Journal of Infection Control, Sept 2011.
- Ng, Multicenter evaluation of bacterial contamination of glucose test strips. Clinica Chimica Acta 413 (2012).